Indoco Remedies informs about press release

03 May 2023 Evaluate

Further to the intimation dated January 23, 2023, on the audit conducted by the United States Food and Drug Administration (USFDA) at its Solid Oral Formulation Facility (Plant 1) at Goa, from January 16, 2023 to January 20, 2023, Indoco Remedies has informed that the Company has received the Establishment Inspection Report (EIR) indicating closure of the inspection. It has enclosed press release in this regard.

The above information is a part of company’s filings submitted to BSE.

Indoco Remedies Share Price

210.20 -4.75 (-2.21%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×